High prevalence of KatG Ser315Thr substitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from northwestern Russia, 1996 to 2001

被引:161
作者
Mokrousov, I
Narvskaya, O
Otten, T
Limeschenko, E
Steklova, L
Vyshnevskiy, B
机构
[1] Res Inst Phthisiopulmonol, Microbiol Lab, St Petersburg, Russia
[2] Inst Pasteur, Mol Microbiol Lab, St Petersburg 197101, Russia
[3] City Anti TB Dispensary, St Petersburg, Russia
关键词
D O I
10.1128/AAC.46.5.1417-1424.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A total of 204 isoniazid (INH)-resistant strains of Mycobacterium tuberculosis isolated from different patients in the northwestern region of Russia from 1996 to 2001 were screened by a PCR-restriction fragment length polymorphism (RFLP) assay. This assay uses HapII cleavage of an amplified fragment of the katG gene to detect the transversion 315AGC-->ACC (Ser-->Thr), which is associated with INH resistance. This analysis revealed a 93.6% prevalence of the katG S315T mutation in strains from patients with both newly and previously diagnosed cases of tuberculosis (TB). This mutation was not found in any of 57 INH-susceptible isolates included in the study. The specificity of the assay was 100%; all isolates that contained the S315T mutation were classified as resistant by a culture-based susceptibility testing method. The Beijing genotype, defined by IS6110-RFLP analysis and the spacer oligonucleotide typing (spoligotyping) method, was found in 60.3% of the INH-resistant strains studied. The katG S315T shift was more prevalent among Beijing genotype strains than among non-Beijing genotype: 97.8 versus 84.6%, respectively, for all isolates, including those from patients with new and previously diagnosed cases, isolated from 1999 to 2001 and 100.0 versus 86.5%, respectively, for isolates from patients with new cases isolated from 1996 to 2001. The design of this PCR-RFLP assay allows the rapid and unambiguous identification of the katG 315ACC mutant allele. The simplicity of the assay permits its implementation into routine practice in clinical microbiology laboratories in regions with a high incidence of TB where this mutation is predominant, including northwestern Russia.
引用
收藏
页码:1417 / 1424
页数:8
相关论文
共 40 条
[1]  
[Anonymous], 1993, TREATMENT TUBERCULOS
[2]   Mapping of IS6110 insertion sites in two epidemic strains of Mycobacterium tuberculosis [J].
Beggs, ML ;
Eisenach, KD ;
Cave, MD .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (08) :2923-2928
[3]   Differentiation of bacterial 16S rRNA genes and intergenic regions and Mycobacterium tuberculosis katG genes by structure-specific endonuclease cleavage [J].
Brow, MAD ;
Oldenburg, MC ;
Lyamichev, V ;
Heisler, LM ;
Lyamicheva, N ;
Hall, JG ;
Eagan, NJ ;
Olive, DM ;
Smith, LM ;
Fors, L ;
Dahlberg, JE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (12) :3129-3137
[4]   Genetic methods for assessing antimicrobial resistance [J].
Cockerill, FR .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (02) :199-212
[5]  
Dobner P, 1997, INT J TUBERC LUNG D, V1, P365
[6]  
Escalante P., 1998, Tubercle and Lung Disease, V79, P111, DOI 10.1054/tuld.1998.0013
[7]   Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997) [J].
Fang, Z ;
Doig, C ;
Rayner, A ;
Kenna, DT ;
Watt, B ;
Forbes, KJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (04) :998-1003
[8]   Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa [J].
Haas, WH ;
Schilke, K ;
Brand, J ;
Amthor, B ;
Weyer, K ;
Fourie, PB ;
Bretzel, G ;
StichtGroh, V ;
Bremer, HJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) :1601-1603
[9]   Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology [J].
Kamerbeek, J ;
Schouls, L ;
Kolk, A ;
vanAgterveld, M ;
vanSoolingen, D ;
Kuijper, S ;
Bunschoten, A ;
Molhuizen, H ;
Shaw, R ;
Goyal, M ;
vanEmbden, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (04) :907-914
[10]   Analysis of ahpC gene mutations in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis [J].
Kelley, CL ;
Rouse, DA ;
Morris, SL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) :2057-2058